Patients using diabetes apps can miss critical alerts. Here's how to make sure you're getting them
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...